More Avecho Biotechnology Limited news
Avecho Biotechnology LimitedASX: AVE

Successful Results -Phase 2 TPM Trentinoin Gel Study on Acne

Mar 30, 2016 at 8:46 AM EDT · Issued by Avecho Biotechnology Limited

Filed with ASX · Mar 30, 2016 at 8:46 AM EDT · 3 pages · English

On 6ix: 6ix.com/news/successful-results-phase-2-tpm-trentinoin-gel-study-on-acne

Avecho Biotechnology Limited on 6ix

Story so far

  • Enrolments Completed for Phase 2 Acne Treatment TrialMar 30, 2016
  • Phosphagenics Collaboration To Develop Anti-acne DrugFeb 11, 2016
  • Phosphagenics to Launch Phase 2 Acne Treatment TrialFeb 11, 2016

Earlier from Avecho Biotechnology

  • Response to an ASX Price QueryMar 30, 2016
  • Positive Results Phase 1B Study Transdermal Oxycodone PatchMar 30, 2016
  • POH Global Agreement with Novartis Animal HealthMar 30, 2016
  • Phosphagenics Launches Australian Skincare ProductsMar 30, 2016
  • June 2010 Half Yearly Appendix 4D and Financial ReportMar 30, 2016

Later from Avecho Biotechnology

  • Phosphagenics Signs Japanese License Option and R&D AllianceApr 29, 2016
  • Phosphagenics Expands Japanese Option to Oxycodone PatchMay 17, 2016
  • Phosphagenics Expands Licence Agreement for Diclofenac GelMay 18, 2016
  • Phosphagenics Initiates Cattle StudyJun 1, 2016
  • Phosphagenics Completes Grower/Finisher Pig StudyJun 29, 2016
All Avecho Biotechnology news releases↗

Follow Avecho Biotechnology into a list and get an email when it puts out news.

Follow Avecho Biotechnology
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer